chr3-180616568-A-G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_181426.2(CCDC39):ā€‹c.2534T>Cā€‹(p.Ile845Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000331 in 1,600,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0017 ( 0 hom., cov: 32)
Exomes š‘“: 0.00019 ( 0 hom. )

Consequence

CCDC39
NM_181426.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 0.770
Variant links:
Genes affected
CCDC39 (HGNC:25244): (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011]
TTC14 (HGNC:24697): (tetratricopeptide repeat domain 14) Predicted to enable nucleic acid binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0050510764).
BP6
Variant 3-180616568-A-G is Benign according to our data. Variant chr3-180616568-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 194907.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00169 (257/152252) while in subpopulation AFR AF= 0.0059 (245/41548). AF 95% confidence interval is 0.00529. There are 0 homozygotes in gnomad4. There are 128 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CCDC39NM_181426.2 linkuse as main transcriptc.2534T>C p.Ile845Thr missense_variant 18/20 ENST00000476379.6 NP_852091.1
TTC14NM_001288582.2 linkuse as main transcriptc.1775-812A>G intron_variant NP_001275511.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CCDC39ENST00000476379.6 linkuse as main transcriptc.2534T>C p.Ile845Thr missense_variant 18/202 NM_181426.2 ENSP00000417960 P2Q9UFE4-1

Frequencies

GnomAD3 genomes
AF:
0.00168
AC:
255
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00587
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000401
AC:
95
AN:
236892
Hom.:
0
AF XY:
0.000343
AC XY:
44
AN XY:
128294
show subpopulations
Gnomad AFR exome
AF:
0.00435
Gnomad AMR exome
AF:
0.000739
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000277
Gnomad OTH exome
AF:
0.000872
GnomAD4 exome
AF:
0.000188
AC:
272
AN:
1448320
Hom.:
0
Cov.:
30
AF XY:
0.000185
AC XY:
133
AN XY:
719412
show subpopulations
Gnomad4 AFR exome
AF:
0.00475
Gnomad4 AMR exome
AF:
0.000889
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000479
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000380
Gnomad4 OTH exome
AF:
0.000451
GnomAD4 genome
AF:
0.00169
AC:
257
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.00172
AC XY:
128
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.00590
Gnomad4 AMR
AF:
0.000720
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000273
Hom.:
0
Bravo
AF:
0.00189
ESP6500AA
AF:
0.00382
AC:
14
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000506
AC:
61
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 17, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Primary ciliary dyskinesia 14 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 29, 2014- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
7.9
DANN
Benign
0.96
DEOGEN2
Benign
0.0099
.;T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.70
T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.0051
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
.;L
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.91
N;N
REVEL
Benign
0.19
Sift
Benign
0.12
T;T
Sift4G
Benign
0.067
T;T
Polyphen
0.0020
.;B
Vest4
0.30
MVP
0.75
MPC
0.063
ClinPred
0.0010
T
GERP RS
2.5
Varity_R
0.043

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139560004; hg19: chr3-180334356; API